Publicaciones en las que colabora con María Carmen Sáiz Sánchez (10)

2023

  1. Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: Longitudinal analysis from a randomized trial

    Atherosclerosis, Vol. 377, pp. 12-23

  2. Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome

    Journal of Alzheimer's Disease, Vol. 95, Núm. 3, pp. 887-899

2022

  1. Association between the Prime Diet Quality Score and depressive symptoms in a Mediterranean population with metabolic syndrome. Cross-sectional and 2-year follow-up assessment from PREDIMED-PLUS study

    British Journal of Nutrition, Vol. 128, Núm. 6, pp. 1170-1179

  2. Integrative development of a short screening questionnaire of highly processed food consumption (sQ-HPF)

    International Journal of Behavioral Nutrition and Physical Activity, Vol. 19, Núm. 1

2021

  1. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396

  2. Fruit and Vegetable Consumption is Inversely Associated with Plasma Saturated Fatty Acids at Baseline in Predimed Plus Trial

    Molecular Nutrition and Food Research, Vol. 65, Núm. 17

2020

  1. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study

    European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206

  2. Dietary quality changes according to the preceding maximum weight: A longitudinal analysis in the predimed-plus randomized trial

    Nutrients, Vol. 12, Núm. 10, pp. 1-15

2019

  1. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

2018

  1. Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

    PLoS ONE, Vol. 13, Núm. 6